Retinoic acid receptor beta — Drug Target

All drugs that target Retinoic acid receptor beta — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Retinoid [EPC]

Marketed (2)

• Panretin · Advanz · Retinoid [EPC] · Oncology
  Panretin works by binding to retinoic acid receptors in the skin, which helps to slow down the growth of cancer cells.
• Differin · Galderma Labs Lp · Retinoid [EPC] · Metabolic
  Differin works by binding to retinoic acid receptors on the skin's surface, which helps to prevent clogged pores and reduce inflammation.